Actively Recruiting
Berlin Registry of Right Heart Interventions to Evaluate Outcomes After Catheter-Based Valve Therapies
Led by Charite University, Berlin, Germany · Updated on 2026-03-19
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating patients who have undergone interventional treatments for valve diseases affecting the right side of the heart, such as tricuspid and pulmonary valve conditions. The study aims to assess the impact of these various catheter-based therapies, including devices like TriClip and Cardioband, on patient outcomes and to identify which patient subgroups benefit the most. This research is observational and conducted primarily in Berlin and Brandenburg. The treatments studied involve catheter-based procedures that address valve problems in the right heart, focusing on techniques for tricuspid regurgitation and stenosis as well as pulmonary regurgitation and stenosis. These interventions are performed mainly with devices such as TriClip and Cardioband. The study includes follow-up examinations to monitor patients after their valve interventions. Participants will be followed with medical history reviews, laboratory tests, and echocardiograms to evaluate heart function and valve performance. Outcomes measured include overall and cardiovascular mortality, hospitalizations for heart failure, and assessments of heart failure symptoms, heart and valve function, and liver and kidney health. The follow-up period includes evaluations approximately two months after the intervention to track these health indicators and patient status.
CONDITIONS
Brief Title
Berlin Registry of Right Heart Interventions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with planned or recent valve interventions of the right heart (tricuspid regurgitation/stenosis, pulmonary regurgitation/stenosis)
- Age over 18 years
- Written, documented consent
You will not qualify if you...
- Patients in care or unable to consent
- Patients who are unable to comply with follow-up examinations
- Patients who are detained in an institution
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - N/A
Participants undergo catheter-based valve therapies for right heart valve diseases such as tricuspid regurgitation using devices like TriClip or Cardioband.
Duration - 2 months after intervention
Participants are monitored for outcomes including mortality, heart failure hospitalizations, and valve and cardiac function after the intervention.
1 to 2 visits within 2 months after intervention
Trial Site Locations
Total: 1 location
1
Charité - Universitätsmedizin Berlin
Berlin, Germany, 10117
Actively Recruiting
Research Team
H
Henryk Dreger, Prof. Dr. med.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here